Share this Article
Singapore Med J 2013; 54: 183-184; http://dx.doi.org/10.11622/smedj.2013069
Role of probiotics and nutrition in the management of chronic inflammatory bowel disease in children
Quah SH
Correspondence: Dr Quak Seng Hock, senghock_quak@nuhs.edu.sg
SUMMARY
In recent years, there has been a great increase in the range of chronic inflammatory conditions in developed countries. Singapore is no exception. In the early 1970s, inflammatory bowel disease was almost unheard of among the paediatric population in Singapore. Over the last few decades, however, there has been a steady rise in the number of Singaporean children suffering from either ulcerative colitis or Crohn’s disease.
Singapore Med J 2013; 54: 183-184; http://dx.doi.org/10.11622/smedj.2013069
REFERENCES
| 1. Himmel ME, Yao Y, Orban PC, Steiner TS, Levings MK. Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology 2012; 136:115-22. http://dx.doi.org/10.1111/j.1365-2567.2012.03572.x |
||||
| 2. Hardenberg G, Steiner TS, Levings MK. Environmental influences on T regulatory cells in inflammatory bowel disease. Semin Immunol 2011; 23:130-8. http://dx.doi.org/10.1016/j.smim.2011.01.012 |
||||
| 3. Park KT, Perez F, Tsai R, et al. Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr 2011; 53:489-96. | ||||
| 4. Miele E, Pascarella F, Giannetti E, et al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009; 104:437-43. http://dx.doi.org/10.1038/ajg.2008.118 |
||||
| 5. Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systemic review of intervention studies in adult patients. Drugs 2012; 72:803-23. http://dx.doi.org/10.2165/11632710-000000000-00000 |
||||
| 6. Whelan K, Quigley EM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013; 29:184-9. http://dx.doi.org/10.1097/MOG.0b013e32835d7bba |
||||
| 7. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol 2011; 45: S139-44. http://dx.doi.org/10.1097/MCG.0b013e31822103f7 |
||||
| 8. Damman CJ, Miller SI, Surawicz CM, Zisman TL. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 2012; 107:1452-9. http://dx.doi.org/10.1038/ajg.2012.93 |
||||
| 9. Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012; 36:503-16. http://dx.doi.org/10.1111/j.1365-2036.2012.05220.x |
||||
| 10. Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 2013; 29:79-84. http://dx.doi.org/10.1097/MOG.0b013e32835a4b3e |
||||
| 11. Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res 2012; 56:524-35. http://dx.doi.org/10.1002/mnfr.201100630 |
||||
| 12.Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet 2011; 24:313-26. http://dx.doi.org/10.1111/j.1365-277X.2011.01171.x |
||||
| 13. Tjellstrom BO, Hogberg L, Stenhammar L, et al. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease. Scand J Gastroenterol 2012; 47:1454-9. http://dx.doi.org/10.3109/00365521.2012.703234 |
||||
| 14. Ong F, Gracia MA, Aw M, Quak SH. The Use of Exclusive Enteral Feeding as Primary Therapy for Crohn's Disease in Singaporean Children and Adolescents (poster). 4th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition 2012; PP15046. | ||||
| 15. de Bie C, Kindermann A, Escher J. Use of exclusive enteral nutrition in paediatric Crohn's disease in The Netherlands. J Crohns Colitis 2013; 7:263-70. http://dx.doi.org/10.1016/j.crohns.2012.07.001 |
||||
| 16. Sazuka S, Katsuno T, Nakagawa T, et al. Concomitant use of enteral nutrition therapy is associated with sustained response to infliximab in patients with Crohn's disease. Eur J Clin Nutr 2012; 66:1219-23. http://dx.doi.org/10.1038/ejcn.2012.120 |
||||
| 17. Lambart B, Lemberg DA, Leach ST, Day AS. Longer-term Outcomes of Nutritional Management of Crohn's Disease in Children. Dig Dis Sci 2012; 57:2171-7 http://dx.doi.org/10.1007/s10620-012-2232-2 |
||||